Abstract:Abstract Objective As nanoscale membrane vesicles, extracellular vesicles (EVs) are actively released by cells and have recently been observed to assume an important role in the treatment of ischemic stroke. However, the source of EVs currently reported for the treatment of ischemic stroke is tightly restricted to mammals. Moreover, these EVs are limited in clinical translation due to the high cost of cell culture. In species other than mammals, Lactobacillus Plantarum culture is low-cost and high-yield. Notwithstanding, it is poorly identified whether Lactobacillus Plantarum -derived EVs (LEVs) can be applied across species for the treatment of ischemic stroke. Methods LEVs were injected into mice via the tail vein immediately after transient middle cerebral artery occlusion (tMCAO) modeling. Infarct volumes, neurological scores, and neuron apoptosis were examined 3 days following the ischemic episode. The expression of microRNA (miRNA) and the target gene in neurons and peri-infarct regions of the post-ischemic brain were measured for mechanistic analyses. Results LEVs crossed the blood-brain barrier and were taken up by neurons both in vitro and in vivo. LEV treatment attenuated neuron apoptosis following oxygen-glucose deprivation (OGD). In vivo findings displayed that LEV treatment substantially reduced neurological deficits and brain infarct size in tMCAO mice. High-throughput sequencing exhibited that miR-101a-3p expression was prominently elevated by LEV treatment in OGD-induced neurons, and corroborating findings were detected in tMCAO mice treated with LEVs. Mechanistically, c-Fos was directly targeted by miR-101a-3p. Moreover, c-Fos manipulated ischemia-induced neuron apoptosis in vitro and in vivo through the TGF-β1 pathway. miR-101a-3p inhibition aggravated ischemia-induced neuron apoptosis in vitro and in vivo, and miR-101a-3p overexpression triggered opposite results. Conclusion Our results elaborated for the first time that LEVs might inhibit neuron apoptosis and injury across species via the miR-101a-3p/c-Fos/TGF-β axis, which may provide novel ideas and targets for the treatment of ischemic stroke and is also of significance for the clinical translation of EVs.

Extracellular vesicles derived from M2 microglia reduce ischemic brain injury through microRNA-135a-5p/TXNIP/NLRP3 axis

M2 Microglial Extracellular Vesicles Attenuated Blood-brain Barrier Disruption Via MiR-23a-5p in Cerebral Ischemic Mice.

M2 microglia-derived extracellular vesicles promote white matter repair and functional recovery via miR-23a-5p after cerebral ischemia in mice

MiR-100-5p-rich small extracellular vesicles from activated neuron to aggravate microglial activation and neuronal activity after stroke

Microglia exosomal miRNA-137 attenuates ischemic brain injury through targeting Notch1

M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124

M2 Microglia Extracellular Vesicle miR-124 Regulates Neural Stem Cell Differentiation in Ischemic Stroke via AAK1/NOTCH

Extracellular vesicles from adipose-derived stem cells promote microglia M2 polarization and neurological recovery in a mouse model of transient middle cerebral artery occlusion

Extracellular Vesicles from Adipose-derived Stem Cells Promote Microglia M2 Polarization and Neurological Recovery after Ischemic Stroke

MicroRNA-140-5p shuttled by microglia-derived extracellular vesicles attenuates subarachnoid hemorrhage-induced microglia activation and inflammatory response via MMD downregulation

M2 microglial small extracellular vesicles reduce glial scar formation via the miR-124/STAT3 pathway after ischemic stroke in mice

Astrocyte‐Derived Extracellular Vesicular miR‐143‐3p Dampens Autophagic Degradation of Endothelial Adhesion Molecules and Promotes Neutrophil Transendothelial Migration after Acute Brain Injury

miR-155-5p in Extracellular Vesicles Derived from Choroid Plexus Epithelial Cells Promotes Autophagy and Inflammation to Aggravate Ischemic Brain Injury in Mice

MicroRNA-193a-5p Rescues Ischemic Cerebral Injury by Restoring N2-Like Neutrophil Subsets

Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice via the TGF-β/Smad2/3 pathway

Abstract TMP30: M2 Microglia Derived Exosomes Promote White Matter Repair and Long-Term Functional Recovery after Focal Cerebral Ischemia in Mice

Therapeutic potential of microglia-derived extracellular vesicles in ischemic stroke

A2 reactive astrocyte-derived exosomes alleviate cerebral ischemia-reperfusion injury by delivering miR-628

M1-type microglia-derived exosomes contribute to blood–brain barrier damage

Serum small extracellular vesicles promote M1 activation of microglia after cerebral ischemia/reperfusion injury

Lactobacillus Plantarum -derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis cross-species